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ABSTRACT Potato virus X (PVX) and some other potexviruses can be reconstituted  in vitro from viral coat 
protein (CP) and RNA. PVX CP is capable of forming viral ribonucleoprotein complexes (vRNP) not only with 
homologous, but also with foreign RNAs. This paper presents the structure and properties of vRNP assembled 
in vitro upon incubation of PVX CP and RNAs of various plant and animal viruses belonging to different taxo-
nomic groups. We have shown that the morphology and translational properties of vRNPs containing foreign 
(heterologous) RNA are identical to those of homological vRNP (PVX RNA – PVX CP). Our data suggest that 
the assembly of the “mixed” vRNP in vitro could be started at the 5’-proximal region of the RNA, producing a 
helical structure of vRNPs with foreign nucleic acids. The formation of heterologous vRNP in vitro with PVX 
CP appears not to require a specific 5’ end RNA nucleotide sequence, and the PVX CP seems to be able to pack 
foreign genetic material of various sizes and compositions into artificial virus-like particles. 
KEYWORDS plant viruses; RNA; viral ribonucleoproteins; translation activation.
ABBREVIATIONS PVX – Potato virus X; CP – coat protein; vRNP – viral ribonucleoprotein; MP – movement 
protein; BMV – Brome mosaic virus; PAMV – Potato aucuba mosaic virus; TMV – Tobacco mosaic virus; NMV – 
Narcissus mosaic virus; AltMV – Altenathera mosaic virus.
INTRODUCTION
The protein capsid of a number of phytoviruses consists 
of identical coat protein subunits folded on the basis of 
helical symmetry. Genomic viral RNA is helically ar-
ranged between the turns of coat protein subunits and 
follows their folding. The possibility of reversible dis-
sociation of virions into coat proteins and RNA followed 
by the in vitro self-assembly of viral ribonucleoproteins 
(vRNP) is an important feature of a number of viruses. 
As a result, the structure and biological activity of the 
virus can be reconstituted. The self-assembly (repolym-
erization) of a low-molecular-weight coat protein can 
occur in the absence of RNA, yielding particles with a 
structure identical to that of viruses, but possessing an 
unlimited length [3].
The self-assembly procedure enables one to obtain a 
“mixed” vRNP consisting of the viral coat protein and 
a heterologous RNA [4, 5]. The fact that it is possible 
to construct viruses containing foreign RNA creates 
the potential for using a “mixed” artificial vRNP to 
target cells and organs of plants and, possibly, animals 
with foreign RNA. It is convenient to use plant viruses 
to form “mixed” vRNPs, since they are highly stable, 
completely biologically safe (there are no pathogens 
common to both plants and animals) and the procedure 
of vRNP assembly is a low-cost one due to the excep-
tionally high level of accumulation of a number of vi-
ruses in an infected plant (4–10 g/kg of leaves).
Another advantage of vRNP is the possibility of 
controllable activation of the translation of the RNA 
encapsulated in the coat protein. Viruses and a 
“mixed” vRNP can change their structure under the 
effect of a number of factors (pH shift, phosphoryla-
tion, and the presence of certain virus-specific acti-
vating proteins).
The spiral viruses of plants, which are rather highly 
stable at high temperatures, non-physiological pH val-
ues of the environment and in the presence of hydro-RESEARCH ARTICLES
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lytic enzymes, are preferable for the construction of 
vRNP. Moreover, the length of a spiral virus depends 
on the size of the nucleic acid; as opposed to isometric 
viruses, hence, vRNP formed in vitro can include RNA 
of unlimited length. Looking ahead, it is reasonable to 
assume that the spiral phytoviruses that are modified 
and reconstructed in a “mixed” manner can serve as 
containers to store and deliver “therapeutic” genes and 
pharmaceutical agents into cells [3].
Potato virus X (PVX) is one of the phytoviruses with 
a spiral structure, a typical representative of Potexvi-
rus genus of the family Flexiviridae. PVX virions are 
flexible thread-like bodies 515 nm long and 13.5  nm 
in diameter. A viral particle contains approximately 
1350 helically folded identical coat protein (CP) subu-
nits and a viral RNA enclosed between the helix turns 
[6]. A turn of the primary PVX helix consists of 8.9 CP 
subunits. The PVX genome consists of a 6345 nt single-
stranded (+)-RNA [7]. The genomic RNA contains a cap 
at its 5’ terminus and a poly(A) sequence at its 3’ ter-
minus [8]. The RNA of PVX encodes five proteins: viral 
replicase (molecular weight of 165 kDa) and four pro-
teins that are responsible for the intercellular and sys-
temic transport of the infected material; three move-
ment proteins (MP1, MP2, and MP3, the products of 
the “triple gene block”) with molecular weights of 25, 
12, and 8 kDa, respectively; and a coat protein with a 
molecular weight of 25 kDa [8].
It has been shown that the coat protein of potexvi-
ruses is capable of forming vRNP in vitro not only with 
the homologous RNA, but with certain heterologous 
RNAs as well [9, 10].
The present study was aimed at investigating the 
structure and the properties of vRNP obtained in vit-
ro by the incubation of PVX CP with the RNA of a 
number of plant and animal viruses belonging to vari-
ous taxonometric groups. The RNAs of potexviruses 
(NMV – narcissus mosaic virus, PAMV – potato aucu-
ba mosaic virus, AltMV – alternanthera mosaic virus), 
tobamovirus (TMV – tobacco mosaic virus), bromovi-
rus (BMV – brome mosaic virus), and Mengo picorna-
virus (animal virus) were used as heterologous RNAs.
EXPERIMENTAL
Purification of PVX specimens, coat 
protein, MP1 and PVX RNA
The PVX specimen (Russian strain) was extracted from 
infected plants Datura stramonium L. according to the 
procedure described by Atabekov et al. [11]. PVX CP 
was obtained by salt deproteinization [12]. RNA was 
extracted using the phenol technique [13] with modi-
fications. Recombinant protein MP1 was obtained ac-
cording to the procedure described earlier [14].
In vitro obtainment of vRNP
In order to obtain vRNP, the RNA and the coat protein 
were mixed at a RNA : CP weight ratio of 1 : 10. The in-
cubation was carried out under the standard conditions 
[15]: in 20 µl of a 0.01 M tris-HCl buffer, pH 7.5 at room 
temperature for 20 min. The reaction was stopped by 
adding bromophenol blue or transferring the incuba-
tion mixture into ice (0°С).
In vitro translation 
RNA translation was carried out in a cell-free protein-
synthesis system consisting of a wheat germ extract 
according to the procedure described earlier [14], in 
the presence of 35S-methionine for 60 min at 25°С. The 
amount of RNA in the sample was 40 µg/µl (for Mengo-
virus RNA, 25 µg/µl). Recombinant MP1 for the trans-
lational activation of RNA within vRNP was added at a 
PVX: MP1 molar ratio = 1 : 100; i.e., 1.4 µg of MP1 per 
1 µg of RNA (20 µg of the virus).
Transmission electron microscopy
The specimens (15 µl) were sorbed onto copper grids for 
electron microscopy, coated with formvar film (a 0.5% 
formvar solution in dichloroethane was used for film 
coating) for 15–20 s. Then, the specimens on the grids 
were contrasted with a 2% uranyl acetate solution and 
viewed on a JEOL JEM-1011 (JEOL, Japan) electron 
microscope at 80 kV. The images were obtained using 
a Gatan Erlangshen ES500W digital camera and Gatan 
Digital Micrograph™ software.
Atomic force microscopy (AFM) 
The scanning was performed on the Nanoscope 3a (Dig-
ital Instruments, Santa Barbara, United States) and 
SmartSPM (Aist-NT, Russia) microscopes in air in the 
resonance mode. The typical scan rate was 1 Hz. Canti-
levers fpN01S with a resonance frequency of 118–190 
kHz, rigidity of 5.3 N/m, and guaranteed needle bend-
ing radius of 10 nm (F.V. Lukin State Research Institute 
of Physical Problems, Russia) were used. FemtoScan 
Online software (Center for Advance Technologies, 
Russia) was used to process and visualize AFM images. 
For sample preparation, 5–10 µl of the specimen at the 
required concentration was applied to freshly cleaved 
mica or highly oriented pyrolytic graphite for 5–10 min. 
Then, the sample was washed twice in a drop of dis-
tilled water and air-dried.
RESULTS AND DISCUSSION
A series of vRNP were obtained by in vitro assembly of 
PVX CP and the RNAs of viruses belonging to various 
taxonomic groups. The RNAs of the following viruses 
were used as heterologous RNA: four potexviruses 
(PVX, NMV, PAMV, and AltMV), tobamovirus (TMV), 42 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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bromovirus (BMV, icosahedral virus with a function-
ally fragmented genome), and Mengo picornavirus 
(animal virus). The homologous RNA of PVX was used 
as a control.
The PVX CP is known not to form virus-like ag -
gregates in the absence of RNA [16]. Particles that are 
morphologically indistinguishable from those obtained 
upon the reconstruction of PVX CP with homologous 
PVX RNA (Fig. 1A) can be observed in a transmission 
electron microscope (TEM) after incubation of PVX 
CP with heterologous RNAs of various viruses at a 
RNA : CP ratio = 1 : 10 (w/w) (Figs. 1B–G). We have 
already demonstrated that homologous vRNP “PVX 
RNA – PVX CP” are structurally identical to native 
PVX virions [15].
The vRNP morphology was analyzed using high-
resolution AFM imaging. The vRNP particles contain-
ing homologous and heterologous RNAs were studied 
using this technique. The images of vRNP obtained 
upon the incubation of PVX CP with heterologous 
RNAs (Fig. 2B–F) are identical to those of homologous 
vRNP (Fig. 2A). The AFM data showed that the aver-
age height of a homologous and heterologous complex 
was 10.0 ± 0.6 and 9.9 ± 0.9 nm, respectively (Fig. 3). 
These values coincide with each other within the limits 
of error and correspond to the height of the native PVX 
(data not shown). As mentioned above, the diameter 
of the PVX virion is 13.5 nm [6]. The heights of the ho-
mologous complexes determined using the AFM tech-
nique agree with this value [17]. However, the height 
and width of a viral particle determined by AFM may 
vary depending on the type of probe used, the method 
of sample preparation, and the value of the force action. 
When performing measurements in air, the height of 
PVX virions is typically underestimated and equal to 
10–11 nm. This is associated with the fact that during 
scanning, the microscope probe imposes pressure on 
the sample and flattens it to a certain extent [18].
TEM and AFM were used previously to detect sin-
gle-tailed particles (STPs) with the 3’ terminus of PVX 
RNA that was vacant of CP, and rod-like heads that 
resulted from the helical folding of the coat protein on 
the 5’ terminal RNA fragment [15].
The 1 : 10 (w/w) RNA : coat protein ratio in the in-
cubation mixture upon vRNP assembly ensures the ab-
sence of excessive unbound CP on the specimen surface. 
On the other hand, this amount of CP is insufficient for 
encapsulation of the entire RNA. As a result, AFM de-
tects the particles in which a part of the RNA molecule 
within vRNP remains unbound to CP (Figs. 2A, B, F). It 
should be noted that not all short vRNPs have unbound 
RNA tails (Figs. 2C–E). This may result from the hy-
drolysis of the 3’ RNA terminus not bound to CP due to 
the action of the ribonucleases in the solution or upon 
loading the particle suspension on the mica surface pri-
or to the analysis.
The self-assembly of RNA with the viral CP leads 
to the formation of a set of vRNPs heterogeneous in 
length (Fig. 3). Particles containing a completely en-
capsidated RNA were not found even when analyzing 
the homologous vRNP (Fig. 3A). The most complete-
ly reconstructed PVX vRNPs reached just 300 nm, 
whereas the modal length of the native virions is 
515 nm. The decrease in vRNP length seems to be the 
result of the deficiency of the coat protein in the incu-
bation mixture (the RNA : CP ratio was 1 : 10 instead 
А   B   C   D
E   F   G
Fig. 1. TEM images of the vRNPs assembled in vitro from homologous or foreign RNA and PVX CP. (A) PVX RNA;  
(B) NMV RNA; (C) PAMV RNA; (D) total BMV RNA; (E) Mengo virus RNA; (F) TMV RNA; (G) AltMV RNA.  
The RNA : CP ratio (w/w) = 1 : 10. The samples were stained with 2% uranyl acetate. Scale bars represent 100 nm. RESEARCH ARTICLES
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of the 1 : 20 ratio that is used to reconstruct the full-
size PVX particles).
The increase in the amount of protein within the 
incubation mixture (calculated per RNA molecule) 
results in an increase in the length of “mixed” (heter-
ologous) particles. Thus, at a RNA : CP ratio = 1 : 10, 
heterologous particles formed after protein “coating” 
of the RNA of potexviruses NMV, PAMV, and tobamo-
virus TMV were characterized by an average length of 
200 nm similar to that of PVX vRNP (Fig. 3A). The size 
of the RNA of these viruses is comparable with that 
of PVX RNA. When using shorter viral RNAs (the to-
tal specimen of BMV RNA consists of four RNAs with 
lengths varying from 800 to 3234 n), the RNA : CP mo-
lar ratio decreased while the number of short particles 
(80–100 nm) increased (Fig. 3B). On the other hand, 
upon incubation of Mengo virus RNA (8400 n) with the 
PVX CP, the molar ratio increased and the average size 
of the particles increased to 400–450 nm (Fig. 3B).
Earlier, we had revealed that the RNA molecule 
within native particles of PVX and homologous single-
tail vRNPs (PVX RNA – PVX CP) is inaccessible for 
translation as opposed to TMV and a number of other 
viruses. However, RNA translation is activated upon 
phosphorylation of PVX CP or upon formation of the 
virion or vRNP with PVX MP1 [11, 15, 19].
In the present work, we studied the translation prop-
erties and specificity of the translation activation  of 
“mixed” vRNPs using MP1.
It was demonstrated in the control experiments that 
interaction between PVX RNA and PVX CP results in 
inhibition of RNA translation within vRNP compared 
to that of unbound RNA (Fig. 4A, 1, 2). The background 
translation level observed (Fig. 4A, 2) may result from 
the presence of unbound RNA because of CP deficiency 
upon incubation [15]. The amount of unbound RNA de-
creases as the RNA : CP molar ratio increases, accompa-
nied by a drop in the background translation level [15].
On the other hand, the interaction between MP1 and 
vRNP consisting of homologous coat proteins and RNA 
results in efficient translation activation of the encap-
sidated PVX RNA (Fig. 4A, 1, 3).
It is worth mentioning that similar results were ob-
tained by analyzing the translational activation of the 
heterologous RNAs within the vRNPs reconstructed 
from PVX CP (Figs. 4B–F). The addition of PVX CP 
to the RNA at the 10 : 1 (w/w) ratio leads to a notice-
able translation suppression of BMV RNA (Fig. 4B, 1, 
2), PAMV RNA (Fig. 4C, 1, 2), NMV RNA (Fig. 4D, 1, 
2), TMV RNA (Fig. 4E, 1, 2), and Mengo virus RNA 
(Fig. 4F, 1, 2) within vRNP as compared with the same 
amount of unbound RNA. Almost complete transla-
tion suppression of encapsidated RNA can be achieved 
by increasing the amount of CP to the RNA  : CP ra-
tio = 1 : 30. Figure 4 shows the results for BMV RNA 
(Fig. 4B, 4), NMV RNA (Fig. 4D, 4), and TMV RNA 
(Fig. 4E, 4). The addition of the MP1 to the “mixed” 
vRNP results in translation activation (Figs. 4B–F, 3), 
the translational efficiency recovering to the level of 
unbound RNA (Figs. 4B–F, 1). The set of peptides that 
are formed upon RNA translation within MP1-activat-
ed vRNP is identical to the products of translation of 
unbound RNA as follows from Fig. 4. The results ob-
tained lead to assume that the structures of the protein 
coats of the “mixed” (heterologous) and homologous 
vRNPs are rather similar.
E   F
А   B
C   D
Fig. 2. AFM images of the vRNPs assembled in vitro from 
homologous or foreign RNA and PVX CP. (A) PVX RNA 
on mica; (B) TMV RNA on mica; (C) NMV RNA on graph-
ite; (D) total BMV RNA on mica; (E) Mengo virus RNA on 
mica; (F) PAMV RNA on mica. The RNA : CP ratio (w/w) 
= 1 : 10. The samples were air-dried. Cantilever oscillation 
frequency 300–350 kHz. Arrowheads point to protein-
free RNA tails. Scale bars represent 1 μm.44 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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We demonstrated previously that protein–protein 
interactions between CP and MP1 play a key role upon 
the MP1-dependent activation of the RNA translation 
within viral particles or homologous vRNPs [15, 20]. 
The fundamental role in the interaction between CP 
and MP1 appears to belong to the C terminus fragment 
of PVX CP [21]. The results of the translational acti-
vation of heterologous RNAs within “mixed” artificial 
vRNPs serve as new evidence of the key role of the coat 
protein in this phenomenon.
Specific recognition of viral RNAs by the structural 
protein plays a key role in the encapsidation of viral 
RNA genomes during the assembly of a viral particle. 
Assembly signals interacting with coat proteins (ori-
gin of assembly, OAS) have been identified in the RNA 
molecules of a number of plant viruses (TMV, BMV, 
turnip crinkle virus) [22–25]. In particular, the signifi-
cance of the 5’ terminus fragment of the genomic RNA 
in the processes of the assembly of the virus and repli-
cation of potexvirus RNA has been demonstrated [26].
Kwon et al. [27] were able to identify  in vitro the 
origin of assembly of PVX within the 5’ terminus 
fragment of PVX RNA (51–84  nt) forming a stem-
loop structure (SL1). Moreover, the regulatory ele-
ments that are required for the binding of RNA to the 
coat protein are shown to be located in the fragment 
1–107 nt of PVX RNA [28]. The data obtained by an 
analysis of the translational properties of heterologous 
vRNPs allow one to assume that the initiation of  in 
vitro assembly of heterologous vRNP also starts at the 
5’ terminus RNA fragment and proceeds in the 5’–3’ 
direction. This conclusion is appropriate for potexvirus 
RNAs (NMV, PAMV). However, the signal for specific 
assemby of TMV is located in the 3’ terminus region; 
the tRNA-like 3’ terminal structure and elements of 
the polymerase gene play a role in assembly initiation 
in BMV. Mengo virus RNA (genus Cardiovirus, family 
Picornaviridae) with a length of 8400 nt contains the 
virus-specific protein VPg [29] at its 5’ terminus; the 
protein is bound to the RNA via the phosphodiester 
bond; its 3’ terminus is polyadenylated [30]. It is not 
quite clear which sites are recognized by the PVX CP 
upon initiation of the “coating” of heterologous RNAs; 
although based on the results of translational activa-
tion, this process is likely to start at the 5’ terminus. It 
is most surprising that the translation of Mengo virus 
RNA, which has an internal translation origin site, is 
also inhibited upon binding to PVX CP and activated 
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Fig. 3. Histograms show-
ing height and length dis-
tribution of vRNP on the 
basis of the AFM data. 
PVX CP was incubated 
with RNA at RNA : PVX 
CP (w/w) ratio = 1 : 10. 
(A) PVX RNA;  
(B) total BMV RNA;  
(C) Mengo virus RNA.RESEARCH ARTICLES
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upon addition of MP1. Thus, it is plausible that the ini-
tiation of vRNP is determined by the protein at least 
in the case of PVX CP, and probably in the case of the 
papaya mosaic virus, too (according to Abouhaidar 
and Bancroft [31]). The assembly of the coat protein 
of PVX and heterologous RNAs is initiated at regions 
that differ considerably in terms of localization and 
structure from the ones in the case of RNA interaction 
with its “own” protein.
It can be assumed under the conditions of our exper-
iment that PVX CP recognizes not a specific nucleotide 
sequence, but a certain structure of the 5’ terminus 
fragment of the RNA, which initiates the formation of 
vRNP.
CONCLUSIONS
The incubation of various foreign heterologous RNAs 
with PVX CP in vitro has been shown to result in 
the formation of the vRNPs having morphology and 
translational properties similar to those of homologous 
vRNPs. It can be assumed that a protein coat will be 
formed upon interaction of a heterologous RNA and 
PVX CP similar to the coat of homologous particles in 
terms of its structure. The in vitro formation of heter-
ologous vRNPs with the participation of PVX CP seems 
to be initiated at the 5’ terminus of an RNA molecule 
and to be independent of the specific nucleotide se-
quence of the 5’ terminus RNA fragment. As a result, 
PVX CP is capable of packaging foreign genetic mate-
rial of different sizes into an artificial virus-like par-
ticle. Neither the heterologous nor homologous RNA 
within vRNP is accessible for ribosomes. However, it 
becomes translationally active upon incubation of the 
resulting vRNPs with PVX MP1. Binding of MP1 to one 
of the termini of the PVX virion induces conformation 
changes in the terminal subunits of the coat protein, 
which results in the destabilization (remodelling) and 
transition of the protein helix into a metastable state. 
The following MP1-dependent translational disassem-
bly of PVX particles occurs rapidly and, most likely, 
in cooperation with the release of unbound RNA and 
protein subunits at early stages of the translation [20]. 
It is quite likely that the same mechanism is responsible 
for the translational activation of “mixed” vRNPs, with 
the participation of MP1, described above.
Coat proteins of plant viruses with a helical struc-
ture could be used to design and deliver into target or-
gans artificial “hybrid” nanoparticles (vRNP) capable 
of in vivo disassembly under the control of various fac-
tors. 
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Fig. 4. In vitro translational activation of RNA within vRNP. 
vRNP are formed upon incubation of PVX CP with homolo-
gous and foreign RNAs at weight ratio = 10 : 1, except 
for lane 4 at sections B, D, E, where the CP : RNA ratio = 
30 : 1. Electrophoretic analysis (in 8–20% denaturating 
polyacrylamide gel) of 35S labeled translation products 
produced in wheat germ extract. (A) PVX RNA; (B) total 
BMV RNA; (C) PAMV RNA; (D) NMV RNA; (E) TMV 
RNA; (F) Mengo virus RNA. Lane 1 is RNA; Lane 2 – RNA 
+ PVX CP; Lane 3 – (RNA + PVX CP) + MP1. 46 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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